abstract |
This invention relates to a novel use of (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol hydrochloride or a salt or solvate thereof, in particular its use in the treatment of anxiety disorders or in the treatment of mixed anxiety-depressive disorder. |